XETRWCH
Market cap3.59bUSD
Dec 23, Last price
69.42EUR
1D
2.81%
1Q
-13.94%
Jan 2017
-29.74%
IPO
-53.15%
Name
Wacker Chemie AG
Chart & Performance
Profile
Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones division offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silicas for use in construction, electronics, automotive, health, and renewable energy industries. The Wacker Polymers division provides binders and polymeric additives, such as dispersible polymer powder and vinyl acetate-ethylene dispersions, which are used in construction, paper, adhesive, paint, coating, and basic chemical industries. The Wacker Biosolutions division offers customized biotech and catalog products for fine chemicals, such as pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone for pharmaceutical actives, food additives, and agrochemicals. The Wacker Polysilicon division produces hyperpure polysilicon for use in semiconductor and solar sectors. The company was founded in 1914 and is headquartered in Munich, Germany. Wacker Chemie AG is a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 6,402,200 -22.01% | 8,209,300 32.25% | 6,207,500 32.29% | |||||||
Cost of revenue | 6,018,300 | 6,752,600 | 5,155,600 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 383,900 | 1,456,700 | 1,051,900 | |||||||
NOPBT Margin | 6.00% | 17.74% | 16.95% | |||||||
Operating Taxes | 59,700 | 334,600 | 265,800 | |||||||
Tax Rate | 15.55% | 22.97% | 25.27% | |||||||
NOPAT | 324,200 | 1,122,100 | 786,100 | |||||||
Net income | 313,600 -74.93% | 1,251,000 55.04% | 806,900 326.48% | |||||||
Dividends | (596,100) | (397,400) | (99,400) | |||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 417,500 | 264,300 | 364,100 | |||||||
Long-term debt | 1,321,100 | 1,337,500 | 1,035,400 | |||||||
Deferred revenue | 222,800 | 224,400 | 56,300 | |||||||
Other long-term liabilities | 1,335,500 | 1,107,000 | 2,374,300 | |||||||
Net debt | (719,500) | (490,200) | (568,500) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 936,300 | 1,125,500 | 1,064,400 | |||||||
CAPEX | (639,600) | (561,200) | (321,300) | |||||||
Cash from investing activities | (107,600) | (701,400) | (639,700) | |||||||
Cash from financing activities | (688,100) | (458,500) | (153,900) | |||||||
FCF | 5,600 | 379,600 | 1,340,300 | |||||||
Balance | ||||||||||
Cash | 1,361,200 | 1,776,200 | 1,666,500 | |||||||
Long term investments | 1,096,900 | 315,800 | 301,500 | |||||||
Excess cash | 2,137,990 | 1,681,535 | 1,657,625 | |||||||
Stockholders' equity | 4,466,400 | 4,916,900 | 3,776,200 | |||||||
Invested Capital | 5,344,610 | 5,892,565 | 5,023,275 | |||||||
ROIC | 5.77% | 20.56% | 14.66% | |||||||
ROCE | 5.11% | 19.14% | 15.72% | |||||||
EV | ||||||||||
Common stock shares outstanding | 49,678 | 49,678 | 49,678 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 802,600 | 1,858,800 | 1,456,100 | |||||||
EV/EBITDA | ||||||||||
Interest | 72,600 | 51,100 | 41,800 | |||||||
Interest/NOPBT | 18.91% | 3.51% | 3.97% |